Gracecast Lung Cancer Audio
- Author: Vários
- Narrator: Vários
- Publisher: Podcast
- Duration: 35:44:44
- More information
Informações:
Synopsis
Oncology experts summarize current and emerging issues in cancer management for patients and caregivers. Information from the Global Resource for Advancing Cancer Education (GRACE) helps people to become informed partners in their care.
Episodes
-
IInterview with Dr. Matthew Horton, Pathologist Part 3: Defining Lung Cancer with Molecular Markers (audio)
04/02/2010 Duration: 09minDr. Matthew Horton, specialist in lung pathology at CellNetix in Seattle, WA, discusses new approaches in molecular profiling of lung cancers.
-
The Emerging Role of Molecular Markers in Non-Small Cell Lung Cancer: a Webinar by Dr. Nathan Pennell (audio)
30/01/2010 Duration: 35minDr. Nathan Pennell, medical oncologist and lung cancer expert at the Cleveland Clinic Foundation, reviews the current evidence and future directions for use of molecular markers such as EGFR, KRAS, ERCC-1, EML4-ALK, and others in NSCLC.
-
Interview with Dr. Matthew Horton, Pathologist Part 2: Neuroendocrine Lung Tumors and Bronchioloalveolar Carcinoma (audio)
28/01/2010 Duration: 12minDr. Matthew Horton, specialist in lung pathology at CellNetix in Seattle, WA, discusses the neuroendocrine spectrum of lung tumors and the evolving views on bronchioloalveolar carcinoma (BAC).
-
Interview with Dr. Matthew Horton, Pathologist Part 1: Basics of Non-Small Cell Lung Cancer Subtypes (audio)
19/01/2010 Duration: 09minDr. Matthew Horton, specialist in lung pathology at CellNetix in Seattle, WA, discusses the basic subtypes of non-small cell lung cancer (NSCLC), methods of interpreting NSCLC histology, and the changing importance of pathology in NSCLC management.
-
Thought Leader Round Table: Drs Laskin and Sandler, Part 2 (audio)
12/01/2010 Duration: 09minLung cancer experts Janessa Laskin and Alan Sandler sit down with medical oncologist Jack West to discuss complex cases. Focus on first line chemo standards and the transition to maintenance therapy.
-
Thought Leader Round Table: Drs Laskin and Sandler, Part 1 (audio)
05/01/2010 Duration: 10minLung cancer experts Janessa Laskin and Alan Sandler sit down with medical oncologist Jack West to discuss complex cases. Focus on never-smokers and EGFR mutation testing.
-
Second Line Treatment of Adv NSCLC: What Drugs and When? (audio)
27/12/2009 Duration: 17minThis slide presentation by Dr. Julie Brahmer, medical oncologist and lung cancer expert at Johns Hopkins University, reviews the factors to be considered in the selection of agents and timing of treatments given after first line therapy for advanced NSCLC.
-
Individualizing Treatment for NSCLC Based on Molecular Factors (audio)
16/12/2009 Duration: 10minThis slide presentation by Dr. George Simon, Director of Thoracic Oncology at Fox Chase Cancer Center, describes emerging molecular variables that are being studied to optimize individualized selection of systemic treatments for NSCLC.
-
Introduction to First Line Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC) (audio)
08/12/2009 Duration: 14minThis slide presentation by Dr. Alan Sandler, medical oncologist and Division Chief of Hematology/Oncology at Oregon Health and Science University, provides an introduction to our current first line treatment options for metastatic NSCLC.
-
Treating Lung Cancer: Past, Present, and Future (audio)
03/12/2009 Duration: 14minThis slide presentation by Dr. Ramiswamy Govindan, medical oncologist at Washington University in St. Louis, offers a broad perspective on the history of treating cancer with chemotherapy, our current treatment approaches, and a preview of emerging technologies that are poised to become a more individualized way of treating cancer.
-
Surgical vs. Non-Surgical Management of Locally Advanced NSCLC (audio)
25/11/2009 Duration: 15minThis slide presentation by Dr. Shirish Gadgeel, medical oncologist at Wayne State University, discusses the considerations and evidence about whether locally advanced (Stage III) NSCLC should be managed surgically or with chemo/radiation alone.
-
Radiation Approaches for Localized NSCLC (audio)
16/11/2009 Duration: 10minThis slide presentation by Dr. Quynh Le, radiation oncologist at Stanford University, describes the emerging new radiation tecnhologies for treating localized NSCLC, particularly stereotactic body radiation therapy (SBRT).
-
Adjuvant (Post-Operative) Therapy for Resected Early Stage NSCLC (audio)
06/11/2009 Duration: 17minThis slide presentation by Dr. Heather Wakelee, medical oncologist at Stanford University, describes the current evidence supporting post-operative treatment of resected non-small cell lung cancer (NSCLC) and leading trials in the field.
-
The Role of Surgery in Management of NSCLC (audio)
24/10/2009 Duration: 14minThis slide presentation by Dr. Ralph Aye, thoracic surgeon and Chief of the Thoracic Oncology Division at Swedish Cancer Institute in Seattle, provides a general introduction to surgical management options for early stage non-small cell lung cancer.
-
Diagnosis and Staging of Lung Cancer: A Pulmonologist's Perspective (audio)
16/10/2009 Duration: 15minThis slide presentation by Dr. Gerard Silvestri, pulmonologist at Medical Univ. of South Carolina, covers the key methods of evaluating a new lung cancer, including initial diagnosis and staging studies.
-
Current Questions and Clinical Trials in Post-Operative/Adjuvant Therapy for Early Stage NSCLC (audio)
06/10/2009 Duration: 12minThis slide presentation by Dr. Heather Wakelee, medical oncologist at Stanford University, describes the key clinical research issues being addressed in post-operative treatment of resected non-small cell lung cancer (NSCLC).
-
Cancer Lifeline Lecture - Part 3, Locally Advanced, Unresectable NSCLC (audio)
11/09/2009 Duration: 13minThis slide presentation is part of a lecture by medical oncologist and lung cancer expert Dr. Jack West, in which he covers the optimal treatment strategies for locally advanced (stage III), unresectable NSCLC.
-
Interview with George Simon on Molecular Variables and Treatment Selection for NSCLC (audio)
04/09/2009 Duration: 15minDr. George Simon, medical oncologist at Fox Chase Cancer Center in Philadelphia, discusses the current evidence and emerging treatment patterns related to molecular variables in treatment of NSCLC.
-
Cancer Lifeline Lecture - Part 2, Adjuvant Chemo for Early Stage NSCLC (audio)
20/08/2009 Duration: 22minThis slide presentation is part of a lecture by medical oncologist and lung cancer expert Dr. Jack West, in which he discusses the evidence supporting the current standard of adjuvant (post-operative) chemotherapy to improve survival for patients with early stage, resected NSCLC.
-
Management Options for Stage IIIA NSCLC: The Outer Limits of Resectability (audio)
20/07/2009 Duration: 09minThis slide presentation by medical oncologist and lung cancer expert Dr. Jack West covers the most common management strategies for stage IIIA N2 node-positive NSCLC, with a particular focus on a comparison of preoperative treatment followed by surgery vs. chemo and radiation without surgery.